HealthEquity Analysts Cut Their Forecasts After Q4 Results

robot
Abstract generation in progress

HealthEquity (NASDAQ: HQY) reported better-than-expected Q4 earnings and raised its FY2027 sales guidance. Despite this, the company’s shares slipped, and several analysts, including those from RBC Capital, JP Morgan, and Barrington Research, maintained their ratings but lowered their price targets for the stock. This comes as the company continues to see strong growth in HSA accounts and assets.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin